Search

everythinglearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Herpes simplex virus infections should be considered in pemphigus patients to avoid unnecessary changes in treatment.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

More precise, personalized therapies are needed for autoimmune diseases.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

Blocking IL-17 might help treat the hair loss condition Lichen planopilaris.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

SLE should be considered in unexplained fevers, even in males.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Lichen planus commonly affects middle-aged adults, often involves limbs and mucosal areas, and can be linked to immune diseases.